Knowledge of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Men Who Have Sex with Men in Denver, Colorado

Overview

Journal AIDS Behav

Specialty Infectious Diseases

Date 2013 Jul 5

PMID 23824227

Citations 23

Authors

Alia A Al-Tayyib

Mark W Thrun

Jason S Haukoos

N Eugene Walls

Affiliations

Soon will be listed here.

Abstract

As part of the National HIV Behavioral Surveillance System among men who have sex with men (MSM) in Denver, Colorado, we assessed knowledge of pre-exposure prophylaxis (PrEP); willingness to use PrEP; and potential changes in risk behaviors among HIV-negative participants reporting sexual activity with a male partner in the preceding 12 months. We examined knowledge of PrEP before (2008) and after (2011) results of the iPrEx trial were available. Of the 425 participants in the 2008 sample, 91 (21 %) were aware of PrEP compared to 131 (28 %) of the 461 participants in the 2011 sample (adjusted prevalence ratio: 1.43, 95 % confidence interval: 1.18, 1.72). Despite the increase in 2011, few MSM in Denver were aware of PrEP. Educating high-risk MSM about the potential utility of PrEP as an adjunct to other effective prevention methods is needed when considering the addition of PrEP to the HIV prevention arsenal.

Citing Articles

Low knowledge levels and high willingness to use oral Pre-Exposure Prophylaxis (PrEP) among Key Populations in Kampala, Uganda: Implications for targeted educational interventions.

Ssuna B, Armstrong-Hough M, Block Ngaybe M, Kalibbala D, Kalyango J, Kiweewa F Res Sq. 2024; .

PMID: 39399668 PMC: 11469517. DOI: 10.21203/rs.3.rs-4943952/v1.

HIV/Pre-Exposure Prophylaxis Knowledge and Acceptability of Rapid HIV Testing Among Transgender Adolescents in a Multidisciplinary Gender Clinic.

Guss C, Pilcher S, Assefa I, Fitzgerald S, Stamoulis C, Woods E Transgend Health. 2024; 9(2):128-135.

PMID: 38585242 PMC: 10998023. DOI: 10.1089/trgh.2021.0163.

Acceptability of daily pre-exposure prophylaxis among adolescent men who have sex with men, travestis and transgender women in Brazil: A qualitative study.

Zucchi E, Couto M, Castellanos M, Dumont-Pena E, Ferraz D, Pinheiro T PLoS One. 2021; 16(5):e0249293.

PMID: 33945527 PMC: 8096080. DOI: 10.1371/journal.pone.0249293.

Acceptability of pre-exposure prophylaxis for HIV prevention: facilitators, barriers and impact on sexual risk behaviors among men who have sex with men in Benin.

Ahouada C, Diabate S, Mondor M, Hessou S, Guedou F, Behanzin L BMC Public Health. 2020; 20(1):1267.

PMID: 32819335 PMC: 7441559. DOI: 10.1186/s12889-020-09363-4.

The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs.

Walters S, Coston B, Neaigus A, Rivera A, Starbuck L, Ramirez V Int J Drug Policy. 2020; 77:102671.

PMID: 32092665 PMC: 7245771. DOI: 10.1016/j.drugpo.2020.102671.

References

Liu A, Kittredge P, Vittinghoff E, Raymond H, Ahrens K, Matheson T . Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men. J Acquir Immune Defic Syndr. 2008; 47(2):241-7. View

. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. MMWR Morb Mortal Wkly Rep. 2012; 61(31):586-9. View

Flash C, Krakower D, Mayer K . The Promise of Antiretrovirals for HIV Prevention. Curr Infect Dis Rep. 2012; 14(2):185-93. PMC: 3901012. DOI: 10.1007/s11908-012-0242-z. View

Abdool Karim S . Top stories of 2008. The prospect of PrEP. AIDS Clin Care. 2009; 21(1):6. View

Mimiaga M, Case P, Johnson C, Safren S, Mayer K . Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr. 2009; 50(1):77-83. PMC: 2659469. DOI: 10.1097/QAI.0b013e31818d5a27. View

Cohen M, Gay C, Kashuba A, Blower S, Paxton L . Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1. Ann Intern Med. 2007; 146(8):591-601. DOI: 10.7326/0003-4819-146-8-200704170-00010. View

. Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep. 2011; 60(3):65-8. View

Cohen M, Holmes C, Padian N, Wolf M, Hirnschall G, Lo Y . HIV treatment as prevention: how scientific discovery occurred and translated rapidly into policy for the global response. Health Aff (Millwood). 2012; 31(7):1439-49. DOI: 10.1377/hlthaff.2012.0250. View

Cohen M, Chen Y, McCauley M, Gamble T, Hosseinipour M, Kumarasamy N . Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011; 365(6):493-505. PMC: 3200068. DOI: 10.1056/NEJMoa1105243. View

10.

Rucinski K, Mensah N, Sepkowitz K, Cutler B, Monica Sweeney M, Myers J . Knowledge and use of pre-exposure prophylaxis among an online sample of young men who have sex with men in New York City. AIDS Behav. 2013; 17(6):2180-4. DOI: 10.1007/s10461-013-0443-y. View

11.

Youle M, Wainberg M . Pre-exposure chemoprophylaxis (PREP) as an HIV prevention strategy. J Int Assoc Physicians AIDS Care (Chic). 2003; 2(3):102-5. DOI: 10.1177/154510970300200302. View

12.

Eisingerich A, Wheelock A, Gomez G, Garnett G, Dybul M, Piot P . Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. PLoS One. 2012; 7(1):e28238. PMC: 3256136. DOI: 10.1371/journal.pone.0028238. View

13.

Fisher M . Preexposure prophylaxis for HIV infection: it's not as easy as ABC. Curr Opin Infect Dis. 2007; 20(1):1-2. DOI: 10.1097/QCO.0b013e328013f421. View

14.

Thigpen M, Kebaabetswe P, Paxton L, Smith D, Rose C, Segolodi T . Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012; 367(5):423-34. DOI: 10.1056/NEJMoa1110711. View

15.

. Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for injecting drug users. MMWR Morb Mortal Wkly Rep. 2013; 62(23):463-5. PMC: 4604844. View

16.

Buchbinder S, Liu A . Pre-exposure prophylaxis and the promise of combination prevention approaches. AIDS Behav. 2011; 15 Suppl 1:S72-9. PMC: 3064892. DOI: 10.1007/s10461-011-9894-1. View

17.

Grant R, Lama J, Anderson P, McMahan V, Liu A, Vargas L . Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010; 363(27):2587-99. PMC: 3079639. DOI: 10.1056/NEJMoa1011205. View

18.

Underhill K, Morrow K, Operario D, Mayer K . Could FDA approval of pre-exposure prophylaxis make a difference? A qualitative study of PrEP acceptability and FDA perceptions among men who have sex with men. AIDS Behav. 2013; 18(2):241-9. PMC: 3968829. DOI: 10.1007/s10461-013-0498-9. View

19.

Gallagher K, Sullivan P, Lansky A, Onorato I . Behavioral surveillance among people at risk for HIV infection in the U.S.: the National HIV Behavioral Surveillance System. Public Health Rep. 2007; 122 Suppl 1:32-8. PMC: 1804113. DOI: 10.1177/00333549071220S106. View

20.

Galindo G, Garrett-Walker J, Hazelton P, Lane T, Steward W, Morin S . Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation. Implement Sci. 2012; 7:116. PMC: 3527231. DOI: 10.1186/1748-5908-7-116. View